参考文献/References:
[1] Naidu SS. Novel percutaneous cardiac assist devices the science of and indications for hemodynamic support[J]. Circulation,2011,123(5):533-543.
[2] Rihal CS, Naidu SS, Givertz MM, et al. 2015 SCAI/ACC/HFSA/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in Cardiovascular Care(Endorsed by the American heart association, the Cardiological society of India, and Sociedad Latino Americana de Cardiología Intervencionista; Affirmation of value by the Canadian association of interventional Cardiology-association Canadienne de Cardiologie d'intervention).[J]. Catheter Cardiovasc Interv,2015,85(7):1112-1114.
[3] Kapur NK, Paruchuri V, Urbano-Morales JA, et al. Mechanically unloading the left ventricle before coronary reperfusion reduces left ventricular wall stress and myocardial infarct size[J]. Circulation,2013,128(4):328-336.
[4] Vahanian A, Auricchio A, Bax J, et al. Guidelines on myocardial revascularization[J]. Eur Heart J, 2010, 31(20):2501-2555.
[5] Saudye H, Garratt KN. Percutaneous assist devices for infarct size reduction[J]. Interven Cardiol Clin,2013,2(3):469-484.
[6] Dandel M, Hetzer R. Myocardial recovery during mechanical circulatory support:cellular, molecular, genomic and organ levels[J]. Heart Lung Vessels,2015, 7(2):110-120.
[7] Werdan K,Gielen S,Ebelt H,et al. Mechanical circulatory support in cardiogenic shock[J]. Eur Heart J,2014,35(3):156-167.
[8] Spiro J, Doshi SN.Use of left ventricular support devices during acute coronary syndrome and percutaneous coronary intervention[J].Curr Cardiol Rep,2014,16(12):544.
[9] Lee JM, Park J, Kang J, et al.The efficacy and safety of mechanical hemodynamic support in patients undergoing high-risk percutaneous coronary intervention with or without cardiogenic shock: Bayesian approach network meta-analysis of 13 randomized controlled trials[J]. J Am Coll Cardiol,2014,64:B19.
[10] Myat A, Patel N, Tehrani S, et al. Percutaneous circulatory assist devices for high-risk coronary intervention[J]. JACC Cardiovasc Interv,2015,8(2):229-244.
[11] Rajdev S, Krishnan P, Irani A, et al. Clinical application of prophylactic percutaneous left ventricular assist device(TandemHeart)in high-risk percutaneous cornary intervention using an arterial preclosure technique:single-center experience[J]. J Invasive Cardiol,2008,20(2):67-72.
[12] Vranckx P,Meliga E, de Jaegere PP,et al. The TandemHeart, percutaneous transseptal left ventricular assist device:a safeguard in high-risk percutaneous cornary interventions.The six-year Rotterdam experience[J].EuroIntervention, 2008,4(3):331-337.
[13] Alli OO, Singh IM, Holmes DR Jr, et al. Percutaneous left ventricular assist device with TandemHeart for high-risk percutaneous coronary intervention: the Mayo Clinic experience[J]. Catheter Cardiovasc Interv,2012,80(5):728-734.
[14] Shah R, Thomson A, Atianzar K, et al. Percutaneous left ventricular support for high-risk PCI and cardiogenic shock:who gets what?[J]. Cardiovasc Revasc Med, 2012,13(2):101-105.
[15] Kovacic JC, Nguyen HT, Karajgikar R, et al. The impella recover 2.5 and TandemHeart ventricular assist devices are safe and associated with equivalent clinical outcomes in patients undergoing high-risk percutaneous coronary intervention[J]. Catheter Cardiovasc Interv,2013,82(1):E28-E37.
[16] Kapur NK, Paruchuri V, Pham DT, et al. Hemodynamic effects of left atrial or left ventricular cannulation for acute circulatory support in a bovine model of left heart injury[J]. ASAIO J,2015,61(3):301-306.
[17] O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J]. Circulation,2013,127(4):e362-e425.
[18] Bruckner BA, Jacob LP, Gregoric ID, et al. Clinical experience with the TandemHeart percutaneous ventricular assist device as a bridge to cardiac transplantation[J]. Tex Heart Inst J,2008,35(4):447-450.
[19] Kar B, Gregoric ID, Basra SS, et al. The percutaneous ventricular assist device in severe refractory cardiogenic shock[J]. J Am Coll Cardiol,2011,57(6):688-696.
[20] Gregoric ID, Kar B, Mesar T, et al. Perioperative use of TandemHeart percutaneous ventricular assist device in surgical repair of postinfarction ventricular septal defect[J]. ASAIO J, 2014, 60(5):529-532.
[21] Brinkman WT, Rosenthal JE, Eichhorn E, et al. Role of a percutaneous ventricular assist device in decision making for a cardiac transplant program[J]. Ann Thorac Surg,2009,88(5):1462-1466.
[22] Russell HM, Kulat B, Zingle N, et al. Successful bridge to transplant using the TandemHeart(R)left ventricular assist device in a pediatric patient[J]. World J Pediatr Congenit Heart Surg, 2012,3(2):249-250.
[23] T Kulat B, Russell HM, Sarwark AE, et al. Modified TandemHeart ventricular assist device for infant and pediatric circulatory support[J]. Ann Thorac Surg, 2014, 98(4):1437-1441.
[24] Friedman PA, Munger TM, Torres N, et al. Percutaneous endocardial and epicardial ablation of hypotensive ventricular tachycardia with percutaneous left ventricular assist in the electrophysiology laboratory[J]. J Cardiovasc Electrophysiol, 2007,18(1):106-109.
[25] Reddy YM, Chinitz L, Mansour M, et al. Percutaneous left ventricular assist devices in ventricular tachycardia ablation: multicenter experience[J]. Circ Arrhythm Electrophysiol,2014,7(2):244-250.
[26] Ostadal P, Mlcek M, Holy F, et al. Direct comparison of percutaneous circulatory support systems in specific hemodynamic conditions in a porcine model[J]. Circ Arrhythm Electrophysiol,2012,5(6):1202-1206.
[27] Gregoric ID, Loyalka P, Radovancevic R, et al. TandemHeart as a rescue therapy for patients with critical aortic valve stenosis[J]. Ann Thorac Surg,2009,88(6):1822-1826.
[28] Piazza N, Serruys PW,de Jaegere P. Feasibility of complex coronary intervention in combination with percutaneous aortic valve implantation in patients with aortic stenosis using percutaneous left ventricular assist device(TandemHeart)[J]. Catheter Cardiovasc Interv,2009,73(2):161-166.
[29] Pitsis AA, Dardas P, Mezilis N, et al. Temporary assist device for postcardiotomy cardiac failure[J]. Ann Thorac Surg,2004,77(4):1431-1433.
[30] Pitsis AA, Visouli AN, Burkhoff D, et al. Feasibility study of a temporary percutaneous left ventricular assist device in cardiac surgery[J]. Ann Thorac Surg, 2007,84(6):1993-1999.
[31] Kapur NK, Paruchuri V, Korabathina R, et al. Effects of a percutaneous mechanical circulatory support device for medically refractory right ventricular failure[J]. J Heart Lung Transplant,2011,30(12):1360-1367.
[32] Kapur NK, Paruchuri V, Jagannathan A, et al. Mechanical circulatory support for right ventricular failure: The TandemHeart in RIght VEntricular Support(THRIVE)Registry[J]. J Heart Lung Transplant,2012,31(4):S110.
[33] Cevik C, Nguyen HU, Civitello AB, et al. Percutaneous ventricular assist device in hypertrophic obstructive cardiomyopathy with cardiogenic shock:bridge to myectomy[J]. Ann Thorac Surg,2012,93(3):978-980.
[34] Khalife WI, Kar B. The TandemHeart pVAD in the treatment of acute fulminant myocarditis[J]. Tex Heart Inst J,2007,34(2):209-213.
[35] Li YW, Rosenblum WD, Gass AL, et al. Combination use of a TandemHeart with an extracorporeal oxygenator in the treatment of five patients with refractory cardiogenic shock after acute myocardial infarction[J]. Am J Ther,2013, 20(2):213-218.